DK3392276T5 - Heterodimermolekyle baseret på strukturel CH3-domæne, og fremgangsmåde til fremstilling samt anvendelse deraf - Google Patents
Heterodimermolekyle baseret på strukturel CH3-domæne, og fremgangsmåde til fremstilling samt anvendelse deraf Download PDFInfo
- Publication number
- DK3392276T5 DK3392276T5 DK16874885.3T DK16874885T DK3392276T5 DK 3392276 T5 DK3392276 T5 DK 3392276T5 DK 16874885 T DK16874885 T DK 16874885T DK 3392276 T5 DK3392276 T5 DK 3392276T5
- Authority
- DK
- Denmark
- Prior art keywords
- domain
- structural
- production
- molecule based
- heterodimer molecule
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/524—CH2 domain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/526—CH3 domain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510938995.0A CN106883297B (zh) | 2015-12-16 | 2015-12-16 | 基于ch3结构域的异二聚体分子、其制备方法及用途 |
| PCT/CN2016/110252 WO2017101828A1 (zh) | 2015-12-16 | 2016-12-16 | 基于ch3结构域的异二聚体分子、其制备方法及用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK3392276T3 DK3392276T3 (da) | 2023-05-01 |
| DK3392276T5 true DK3392276T5 (da) | 2024-09-23 |
Family
ID=59055700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16874885.3T DK3392276T5 (da) | 2015-12-16 | 2016-12-16 | Heterodimermolekyle baseret på strukturel CH3-domæne, og fremgangsmåde til fremstilling samt anvendelse deraf |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US11168149B2 (enExample) |
| EP (2) | EP3392276B1 (enExample) |
| JP (3) | JP7103603B2 (enExample) |
| CN (4) | CN106883297B (enExample) |
| CA (1) | CA3007427C (enExample) |
| DK (1) | DK3392276T5 (enExample) |
| ES (1) | ES2944553T3 (enExample) |
| FI (1) | FI3392276T3 (enExample) |
| WO (1) | WO2017101828A1 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106883297B (zh) | 2015-12-16 | 2019-12-13 | 苏州康宁杰瑞生物科技有限公司 | 基于ch3结构域的异二聚体分子、其制备方法及用途 |
| SG10201913263SA (en) | 2016-09-29 | 2020-03-30 | Beijing Hanmi Pharmaceutical Co Ltd | Heterodimeric immunoglobulin constructs and preparation methods thereof |
| WO2018090950A1 (zh) | 2016-11-18 | 2018-05-24 | 北京韩美药品有限公司 | 抗pd‐1/抗her2天然抗体结构样异源二聚体形式双特异抗体及其制备 |
| WO2018228442A1 (en) * | 2017-06-14 | 2018-12-20 | Dingfu Biotarget Co., Ltd. | Proteinaceous heterodimer and use thereof |
| WO2018233624A1 (zh) | 2017-06-20 | 2018-12-27 | 和迈生物科技有限公司 | 抗Her2纳米抗体及其编码序列和用途 |
| WO2019014912A1 (zh) * | 2017-07-21 | 2019-01-24 | 赵磊 | 一种异二聚体蛋白及其制备方法 |
| CN111315767B (zh) * | 2017-08-22 | 2025-03-18 | 萨纳生物有限责任公司 | 可溶性干扰素受体及其用途 |
| WO2019047885A1 (en) | 2017-09-07 | 2019-03-14 | Dingfu Biotarget Co., Ltd. | IMMUNOCONJUGATES COMPRISING ALPHA REGULATORY SIGNAL PROTEIN |
| JP7356726B2 (ja) * | 2017-09-25 | 2023-10-05 | ディンフー バイオターゲット カンパニー リミテッド | タンパク性ヘテロ二量体及びその使用 |
| US11883503B2 (en) | 2017-09-25 | 2024-01-30 | Dingfu Biotarget Co., Ltd. | Methods and compositions for cancer treatment |
| CA3084626A1 (en) | 2017-12-04 | 2019-06-13 | Beijing Hanmi Pharmaceutical Co., Ltd. | Anti-pd-l1/anti-cd47 bispecific antibody with structure like natural antibody and in form of heterodimer and preparation thereof |
| WO2019153200A1 (zh) | 2018-02-08 | 2019-08-15 | 北京韩美药品有限公司 | 抗pd-1/抗her2天然抗体结构样异源二聚体形式双特异抗体及其制备 |
| US11827697B2 (en) | 2018-02-11 | 2023-11-28 | Beijing Hanmi Pharmaceutical Co., Ltd. | Anti-PD-1/anti-VEGF natural antibody structure like heterodimeric form bispecific antibody and preparation thereof |
| CN108640997A (zh) * | 2018-05-22 | 2018-10-12 | 蔡毓旻 | 一种双特异性抗体 |
| US20220227827A1 (en) * | 2019-03-25 | 2022-07-21 | Dingfu Biotarget Co., Ltd. | Proteinaceous heterodimer and use thereof |
| JP2022525275A (ja) * | 2019-03-28 | 2022-05-12 | エービー ストゥーディオ インコーポレイテッド | ヘテロ多量体タンパク質及びその使用法 |
| EP3959237A1 (en) * | 2019-04-25 | 2022-03-02 | F. Hoffmann-La Roche AG | Therapeutic multispecific polypeptides activated by polypeptide chain exchange |
| AU2020263910A1 (en) * | 2019-04-25 | 2021-10-21 | F. Hoffmann-La Roche Ag | Activatable therapeutic multispecific polypeptides with extended half-life |
| JP7812230B2 (ja) * | 2019-04-25 | 2026-02-09 | エフ． ホフマン－ラ ロシュ アーゲー | ポリペプチド鎖交換による抗体由来ポリペプチドの生成 |
| CA3149939A1 (en) | 2019-09-06 | 2021-03-11 | Stephen J. Demarest | Proteins comprising t-cell receptor constant domains |
| CN113121696A (zh) * | 2019-12-31 | 2021-07-16 | 周易 | Fab改造诱导形成的双特异性抗体及其制备方法和用途 |
| CN113121697B (zh) * | 2019-12-31 | 2023-06-09 | 周易 | Ch3结构域改造诱导形成的异源二聚体及其制备方法和应用 |
| TWI920054B (zh) * | 2020-01-23 | 2026-04-01 | 瑞士商天演藥業公司 | 具有Ｆｃ突變之異二聚蛋白質 |
| WO2022032005A2 (en) | 2020-08-05 | 2022-02-10 | Synthekine, Inc. | Il10rb binding molecules and methods of use |
| WO2022031890A1 (en) | 2020-08-05 | 2022-02-10 | Synthekine, Inc. | Ifngr2 binding molecules and methods of use |
| JP7743500B2 (ja) | 2020-08-05 | 2025-09-24 | シンセカイン インコーポレイテッド | Ｉｌ１０受容体結合性分子および使用方法 |
| US20230279125A1 (en) * | 2020-08-05 | 2023-09-07 | Synthekine, Inc. | Il28ra binding molecules and methods of use |
| US12122839B2 (en) | 2020-08-05 | 2024-10-22 | Synthekine, Inc. | IFNGR binding synthetic cytokines and methods of use |
| WO2022093857A1 (en) * | 2020-10-26 | 2022-05-05 | City Of Hope | Oncolytic virus compositions and methods for the treatment of cancer |
| CN112977908B (zh) * | 2021-03-02 | 2022-12-02 | 康宁杰瑞(吉林)生物科技有限公司 | 灌装加塞机及其灌装的方法 |
| KR20240028452A (ko) * | 2021-07-02 | 2024-03-05 | 제넨테크, 인크. | 암을 치료하기 위한 방법 및 조성물 |
| IL309120A (en) * | 2021-07-28 | 2024-02-01 | Hoffmann La Roche | Methods and compositions for the treatment of cancer |
| KR20240116743A (ko) * | 2021-11-09 | 2024-07-30 | 한양대학교 산학협력단 | Fc 변이체를 포함하는 이종이합체 및 이의 제조방법 |
| CN116948029A (zh) * | 2022-04-20 | 2023-10-27 | 南京融捷康生物科技有限公司 | 一种包含IgG类Fc区变体的抗体及其用途 |
| WO2025224084A1 (en) | 2024-04-22 | 2025-10-30 | Engimmune Therapeutics Ag | Proteins comprising t cell receptor constant domains |
| US20260109746A1 (en) | 2024-10-22 | 2026-04-23 | Gilead Sciences, Inc. | Cd4-targeted il-15 molecules and methods of use |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5731168A (en) * | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US7951917B1 (en) * | 1997-05-02 | 2011-05-31 | Genentech, Inc. | Method for making multispecific antibodies having heteromultimeric and common components |
| EP3663318A1 (en) | 2008-01-07 | 2020-06-10 | Amgen Inc. | Method for making antibody fc-heterodimeric molecules using electrostatic steering effects |
| US20130089554A1 (en) * | 2009-12-29 | 2013-04-11 | Emergent Product Development Seattle, Llc | RON Binding Constructs and Methods of Use Thereof |
| CN103429620B (zh) | 2010-11-05 | 2018-03-06 | 酵活有限公司 | 在Fc结构域中具有突变的稳定异源二聚的抗体设计 |
| JP2014511836A (ja) | 2011-03-25 | 2014-05-19 | グレンマーク ファーマシューティカルズ， エセ．アー． | ヘテロ二量体免疫グロブリン |
| UA117901C2 (uk) * | 2011-07-06 | 2018-10-25 | Ґенмаб Б.В. | Спосіб посилення ефекторної функції вихідного поліпептиду, його варіанти та їх застосування |
| US9574010B2 (en) * | 2011-11-04 | 2017-02-21 | Zymeworks Inc. | Stable heterodimeric antibody design with mutations in the Fc domain |
| CN102558355B (zh) * | 2011-12-31 | 2015-02-25 | 苏州康宁杰瑞生物科技有限公司 | 基于电荷网络的异二聚体fc改造方法及异二聚体蛋白的制备方法 |
| WO2013157953A1 (en) * | 2012-04-20 | 2013-10-24 | Merus B.V. | Methods and means for the production of ig-like molecules |
| JP6351572B2 (ja) * | 2012-05-10 | 2018-07-04 | ザイムワークス，インコーポレイテッド | Ｆｃドメインに突然変異を有する免疫グロブリン重鎖のヘテロ多量体構築物 |
| BR112015000798A2 (pt) | 2012-07-13 | 2017-06-27 | Zymeworks Inc | heterodímeros assimétricos biespecíficos compreendendo construtos anti-cd3 |
| CN102851338A (zh) | 2012-07-25 | 2013-01-02 | 苏州康宁杰瑞生物科技有限公司 | 利用电荷排斥作用制备同二聚体蛋白混合物的方法 |
| EA032681B1 (ru) * | 2012-11-27 | 2019-07-31 | Аджоу Юниверсити Индастри-Академик Кооперейшн Фаундейшн | ГЕТЕРОДИМЕР Fc ИММУНОГЛОБУЛИНА, СОДЕРЖАЩИЙ ВАРИАНТ ДОМЕНА CH3 ДЛЯ ОБРАЗОВАНИЯ АНТИТЕЛА ИЛИ ГИБРИДНОГО БЕЛКА С ГЕТЕРОМЕРНЫМ Fc С ВЫСОКОЙ ЭФФЕКТИВНОСТЬЮ, СПОСОБ ДЛЯ ЕГО ПОЛУЧЕНИЯ И ИСПОЛЬЗОВАНИЯ |
| MX385344B (es) * | 2012-11-28 | 2025-03-18 | Zymeworks Bc Inc | Pares de cadena pesada-cadena ligera de inmunoglobulina modificados genéticamente y usos de estos. |
| CN106883297B (zh) * | 2015-12-16 | 2019-12-13 | 苏州康宁杰瑞生物科技有限公司 | 基于ch3结构域的异二聚体分子、其制备方法及用途 |
| KR20180104148A (ko) * | 2016-02-05 | 2018-09-19 | 젠맵 에이/에스 | 개선된 내재화 특징을 갖는 다중특이적 항원-결합 분자 |
| WO2018228442A1 (en) * | 2017-06-14 | 2018-12-20 | Dingfu Biotarget Co., Ltd. | Proteinaceous heterodimer and use thereof |
| WO2019047885A1 (en) * | 2017-09-07 | 2019-03-14 | Dingfu Biotarget Co., Ltd. | IMMUNOCONJUGATES COMPRISING ALPHA REGULATORY SIGNAL PROTEIN |
| JP7356726B2 (ja) * | 2017-09-25 | 2023-10-05 | ディンフー バイオターゲット カンパニー リミテッド | タンパク性ヘテロ二量体及びその使用 |
| US11883503B2 (en) * | 2017-09-25 | 2024-01-30 | Dingfu Biotarget Co., Ltd. | Methods and compositions for cancer treatment |
-
2015
- 2015-12-16 CN CN201510938995.0A patent/CN106883297B/zh active Active
-
2016
- 2016-12-16 EP EP16874885.3A patent/EP3392276B1/en active Active
- 2016-12-16 FI FIEP16874885.3T patent/FI3392276T3/fi active
- 2016-12-16 WO PCT/CN2016/110252 patent/WO2017101828A1/zh not_active Ceased
- 2016-12-16 DK DK16874885.3T patent/DK3392276T5/da active
- 2016-12-16 EP EP23162270.5A patent/EP4234584B1/en active Active
- 2016-12-16 CN CN202210544074.6A patent/CN115057937B/zh active Active
- 2016-12-16 ES ES16874885T patent/ES2944553T3/es active Active
- 2016-12-16 JP JP2018531643A patent/JP7103603B2/ja active Active
- 2016-12-16 CN CN202511005700.4A patent/CN120842427A/zh active Pending
- 2016-12-16 US US16/062,405 patent/US11168149B2/en active Active
- 2016-12-16 CN CN201680073286.3A patent/CN108473592B/zh active Active
- 2016-12-16 CA CA3007427A patent/CA3007427C/en active Active
-
2021
- 2021-10-07 US US17/496,240 patent/US12281177B2/en active Active
-
2022
- 2022-06-28 JP JP2022103464A patent/JP7444381B2/ja active Active
-
2024
- 2024-02-13 JP JP2024019083A patent/JP7788113B2/ja active Active
-
2025
- 2025-03-19 US US19/084,362 patent/US20250257150A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN106883297A (zh) | 2017-06-23 |
| EP3392276B1 (en) | 2023-04-19 |
| WO2017101828A1 (zh) | 2017-06-22 |
| JP2019502701A (ja) | 2019-01-31 |
| JP7788113B2 (ja) | 2025-12-18 |
| EP3392276A1 (en) | 2018-10-24 |
| US20180362668A1 (en) | 2018-12-20 |
| ES2944553T3 (es) | 2023-06-22 |
| EP3392276A4 (en) | 2019-09-18 |
| FI3392276T3 (fi) | 2023-05-05 |
| EP4234584B1 (en) | 2025-07-16 |
| US20250257150A1 (en) | 2025-08-14 |
| HK1253248A1 (zh) | 2019-06-14 |
| CN115057937A (zh) | 2022-09-16 |
| JP2024056829A (ja) | 2024-04-23 |
| JP7444381B2 (ja) | 2024-03-06 |
| DK3392276T3 (da) | 2023-05-01 |
| CN108473592B (zh) | 2022-05-03 |
| CA3007427C (en) | 2024-04-23 |
| CN115057937B (zh) | 2025-07-18 |
| EP4234584A3 (en) | 2023-09-27 |
| EP4234584A2 (en) | 2023-08-30 |
| CA3007427A1 (en) | 2017-06-22 |
| US11168149B2 (en) | 2021-11-09 |
| CN106883297B (zh) | 2019-12-13 |
| EP4234584C0 (en) | 2025-07-16 |
| US12281177B2 (en) | 2025-04-22 |
| CN108473592A (zh) | 2018-08-31 |
| CN120842427A (zh) | 2025-10-28 |
| JP2022130568A (ja) | 2022-09-06 |
| JP7103603B2 (ja) | 2022-07-20 |
| US20220017643A1 (en) | 2022-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3392276T3 (da) | Heterodimermolekyle baseret på strukturel CH3-domæne, og fremgangsmåde til fremstilling samt anvendelse deraf | |
| IL264142A (en) | Multispecific antibodies against cd40 and cd137 | |
| IL259305B1 (en) | Additive manufacturing apparatus, system, and method | |
| IL250588B (en) | Metrology method, target and substrate | |
| DK3538864T3 (da) | Mikrotom | |
| IL249981A0 (en) | Method | |
| BR112016026939A2 (pt) | aparelho e método. | |
| DK3138081T3 (da) | System og fremgangsmåde til opnåelse af køretøjs-telematikdata | |
| PL3301990T3 (pl) | Sposób i przyrząd do ustanawiania powiązania | |
| BR112016026035A2 (pt) | método e dispositivo de obtenção de certificados. | |
| DE102014017707A8 (de) | Beschichtungsverfahren und entsprechende Beschichtungsanlage | |
| BR112017012364A2 (pt) | pré-tratamento rápido. | |
| IL261341B (en) | Branch instruction | |
| IL256187B (en) | Inspection substrate and inspection method | |
| DK3268555T3 (da) | Elongated composite profile and method for mounting the same | |
| IL259462B (en) | A measurement substrate and a measurement method | |
| EP3172897C0 (en) | ENCODER, DECODER AND METHOD | |
| DK3256546T3 (da) | Depolymeriseringsfremgangsmåde | |
| DK3265443T3 (da) | Pyrrolidincarboxamidderivater og fremgangsmåde til fremstilling og anvendelse af samme | |
| EP3184232C0 (en) | DRILLING DEVICE, METHOD AND USE | |
| DK4006174T3 (da) | Aflang tane til optagelse af et dyreskind og fremgangsmåde til fremstilling deraf | |
| DK3237691T3 (da) | Køretøjsystem og -fremgangsmåde | |
| DK3589742T3 (da) | Fremgangsmåde til detektering | |
| PL3250042T3 (pl) | Kompozycja, sposób, zastosowanie i wyrób | |
| DK3107554T3 (da) | Antistof til påvirkning af kønsforholdet og metoder til anvendelse deraf |